Home > Insider Trading > Filing (0001209191-21-035763)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1651944	Dermtech Inc.	DMTK	Services-Medical Laboratories (8071)	842870849

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1787129	Enrico Picozza	C/O Dermtech, Inc. 11099 N. Torrey Pines Rd. Suite 100 La Jolla CA 92037		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-05-21	18,796	$37.27	531,204	No	4	S	Indirect	By HLM Venture Partners IV, L.P.
Common Stock	Disposition	2021-05-21	6,204	$37.80	525,000	No	4	S	Indirect	By HLM Venture Partners IV, L.P.
Common Stock	Disposition	2021-05-25	4,703	$40.01	520,297	No	4	S	Indirect	By HLM Venture Partners IV, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By HLM Venture Partners IV, L.P.
No	4	S	Indirect	By HLM Venture Partners IV, L.P.
No	4	S	Indirect	By HLM Venture Partners IV, L.P.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	14,000	Direct

Footnotes

This transaction was executed in multiple trades at prices ranging from $36.63 to $37.62, inclusive. The reported price reflects the weighted-average sale price.
The reporting person has a pecuniary interest in HLM Venture Associates IV, LLC ("HLM GP"). HLM GP is the general partner of HLM Venture Partners IV, L.P., which owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
This transaction was executed in multiple trades at prices ranging from $37.63 to $38.15, inclusive. The reported price reflects the weighted-average sale price.
This transaction was executed in multiple trades at prices ranging from $40.00 to $40.06, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3) and (4) of this Form 4.